Turkish Validity and Reliability Study of Diabetes-Specific Nutrition Knowledge Questionnaire in Adolescents With Type 1 Diabetes

NCT ID: NCT07232381

Last Updated: 2025-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-01

Study Completion Date

2024-07-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is aimed to contribute to the Turkish Nutrition Sciences literature and shed light on the studies of future generations by establishing the Turkish validity and reliability of this scale, which was developed for adolescents with type 1 diabetes and their parents and was designed to evaluate general and diabetes-specific nutrition knowledge.

Hypotheses:

* H1: Diabetes-Specific Nutrition Information Scale for Adolescents with Type 1 Diabetes is a reliable tool for the Turkish population.
* H2: Diabetes-Specific Nutrition Information Scale for Adolescents with Type 1 Diabetes is a valid tool for the Turkish society.
* H3: Individuals with higher scores on the Diabetes-Specific Nutrition Information Scale in Adolescents with Type 1 Diabetes have better metabolic control.
* H4: Diet quality of individuals with higher scores on the Diabetes-Specific Nutrition Information Scale for Adolescents with Type 1 Diabetes is better.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim is to analyze the validity and reliability of the Diabetes-Specific Nutrition Information Scale in Adolescents with Type 1 Diabetes for the Turkish population. In this context, the relationship between nutritional knowledge levels, glycemic control and diet quality will be investigated with the Nutrition Knowledge Scale in Adolescents with Type 1 Diabetes.

The sample of the study consists of individuals between the ages of 10-19 with Type 1 diabetes registered at Ege University Faculty of Medicine, Department of Child Health and Diseases, Pediatric Endocrine Department, in Izmir province, and their parents. In the first stage, it will be validated with the Brislin method for Turkish language validity. Later, validity and reliability analysis will be conducted. The relationship between individuals' nutritional knowledge levels and diet quality (adapted to Healthy Eating Index-2015 TÜBER-2022) and metabolic control (with last measured HbA1c) will be examined. The case report form created for this purpose, the food consumption monitoring form, SYI-2015 adapted to TÜBER 2022 and the Turkish version of the Diabetes-Specific Nutrition Information Scale in Adolescents with Type 1 Diabetes will be used.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 1 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Child

The population of the study consists of adolescent individuals with type 1 diabetes between the ages of 10 and 19 who were diagnosed with diabetes at least one year ago. The sample of the study consists of adolescents with type 1 diabetes and their parents, who were followed up for diabetes at Ege University Faculty of Medicine Department of Child Health and Diseases, Pediatric Endocrine Department in Izmir, who met the inclusion criteria for the study and approved the informed consent form.

No interventions assigned to this group

Parent

The population of the study consists of adolescent individuals with type 1 diabetes between the ages of 10 and 19 who were diagnosed with diabetes at least one year ago. The sample of the study consists of adolescents with type 1 diabetes and their parents, who were followed up for diabetes at Ege University Faculty of Medicine Department of Child Health and Diseases, Pediatric Endocrine Department in Izmir, who met the inclusion criteria for the study and approved the informed consent form.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* duration of T1D of at least one year,
* regular follow-up of at least 1 year,
* no major medical problems (celiac disease, cystic fibrosis, psychiatric disorders, and communication difficulties)
* the insulin requirement was \> 0.5 IU/kg/day

Exclusion Criteria

* type 1 diabetes duration less than 1 year
* no regular follow-up of at least 1 year
* have major medical problems (celiac disease, cystic fibrosis, psychiatric disorders, and communication difficulties) the requirement was \<0.5 IU/kg/day
Minimum Eligible Age

9 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Izmir Tinaztepe University

OTHER

Sponsor Role collaborator

Yasemin Atik Altinok

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yasemin Atik Altinok

Dr.Dyt.

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ege University, Medical Faculty, Division of Pediatric Endocrinology

Izmir, İzmir, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

23-11.1T/35

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.